Variant report
Variant | esv3402742 |
---|---|
Chromosome Location | chr2:206241003-206241302 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs570628174 | chr2:206241029-206241030 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs149107706 | chr2:206241034-206241035 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs531226302 | chr2:206241045-206241046 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs549783283 | chr2:206241056-206241057 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs143199564 | chr2:206241070-206241071 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs377677532 | chr2:206241090-206241091 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs530466381 | chr2:206241103-206241104 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs144032037 | chr2:206241117-206241118 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs370525706 | chr2:206241124-206241125 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs548890724 | chr2:206241151-206241152 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs79490674 | chr2:206241161-206241162 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs76060154 | chr2:206241162-206241163 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs567079044 | chr2:206241170-206241171 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs546288368 | chr2:206241197-206241198 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs376569040 | chr2:206241266-206241267 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs35550118 | chr2:206241271-206241272 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs552412373 | chr2:206241296-206241297 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ependymoma | 16718352 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Lung cancer | 18438408 | CNVD |
Glioblastoma | 21080181 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Papillary thyroid carcinoma | 22161024 | CNVD |
Cervical cancer | 21062161 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Prostate cancer | 16573809 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Cancer | 20164920 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:206240000-206241200 | Enhancers | NHDF-Ad | bronchial |
2 | chr2:206240400-206241200 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
3 | chr2:206240400-206243000 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
4 | chr2:206240800-206241200 | Enhancers | Fetal Muscle Leg | muscle |
5 | chr2:206240800-206241400 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
6 | chr2:206240800-206241400 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
7 | chr2:206241000-206242800 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
8 | chr2:206241200-206242600 | Weak transcription | Foreskin Fibroblast Primary Cells skin01 | Skin |